This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Demangel, C. Articles by Cole, S. T. Search for Related Content PubMed PubMed Citation Articles by Demangel, C. Articles by Cole, S. T.

Cell Envelope Protein PPE68 Contributes to Mycobacterium tuberculosis RD1 Immunogenicity Independently of a 10-Kilodalton Culture Filtrate Protein and ESAT-6

Unité de Génétique Moléculaire Bactérienne,¹ Unité de Biologie des Régulations Immunitaires, INSERM E352, Institut Pasteur, 75724 Paris Cedex 15, France,³ VLA Weybridge, Department of Bacterial Diseases, TB Research Group, Addlestone, Surrey, United Kingdom²

Received 21 October 2003/ Returned for modification 16 December 2003/ Accepted 9 January 2004

The protective efficacy of Mycobacterium bovis BCG can be markedly augmented by stable integration of Mycobacterium tuberculosis genomic region RD1. BCG complemented with RD1 (BCG::RD1) encodes nine additional proteins. Among them, 10-kDa culture filtrate protein (CFP-10) and ESAT-6 (6-kDa early secreted antigenic target) are low-molecular-weight proteins that induce potent Th1 responses. Using pools of synthetic peptides, we have examined the potential immunogenicity of four other RD1 products (PE35, PPE68, Rv3878, and Rv3879c). PPE68, the protein encoded by rv3873, was the only one to elicit gamma interferon (IFN-)-producing cells in C57BL/6 mice infected with M. tuberculosis. Anti-PPE68 T cells were predominantly raised against an epitope mapped in the N-terminal end of the protein. Importantly, inactivation of rv3873 in BCG::RD1 did not modify CFP-10 and ESAT-6 secretion. Moreover, the generation of IFN- responses to these antigens following immunization with BCG::RD1 was independent of PPE68 expression. Taken together, these results show that PPE68 is an immunogenic product of the RD1 region, which does not interfere with the secretion and immunogenicity of CFP-10 and ESAT-6.

Editor: S. H. E. Kaufmann

This article has been cited by other articles:

• Mustafa, A. S., Al-Attiyah, R., Hanif, S. N. M., Shaban, F. A. (2008). Efficient Testing of Large Pools of Mycobacterium tuberculosis RD1 Peptides and Identification of Major Antigens and Immunodominant Peptides Recognized by Human Th1 Cells. CVI 15: 916-924 [Abstract] [Full Text]  
• Khan, N., Alam, K., Nair, S., Valluri, V. L., Murthy, K. J. R., Mukhopadhyay, S. (2008). Association of Strong Immune Responses to PPE Protein Rv1168c with Active Tuberculosis. CVI 15: 974-980 [Abstract] [Full Text]  
• Choi, J. C., Shin, J. W., Kim, J. Y., Park, I. W., Choi, B. W., Lee, M.-K. (2008). The Effect of Previous Tuberculin Skin Test on the Follow-up Examination of Whole-Blood Interferon-{gamma} Assay in the Screening for Latent Tuberculosis Infection. Chest 133: 1415-1420 [Abstract] [Full Text]  
• Leyten, E. M. S., Mulder, B., Prins, C., Weldingh, K., Andersen, P., Ottenhoff, T. H. M., van Dissel, J. T., Arend, S. M. (2006). Use of Enzyme-Linked Immunospot Assay with Mycobacterium tuberculosis- Specific Peptides for Diagnosis of Recent Infection with M. tuberculosis after Accidental Laboratory Exposure.. J. Clin. Microbiol. 44: 1197-1201 [Abstract] [Full Text]  
• Brodin, P., Majlessi, L., Marsollier, L., de Jonge, M. I., Bottai, D., Demangel, C., Hinds, J., Neyrolles, O., Butcher, P. D., Leclerc, C., Cole, S. T., Brosch, R. (2006). Dissection of ESAT-6 System 1 of Mycobacterium tuberculosis and Impact on Immunogenicity and Virulence. Infect. Immun. 74: 88-98 [Abstract] [Full Text]  
• Zanetti, S., Bua, A., Delogu, G., Pusceddu, C., Mura, M., Saba, F., Pirina, P., Garzelli, C., Vertuccio, C., Sechi, L. A., Fadda, G. (2005). Patients with Pulmonary Tuberculosis Develop a Strong Humoral Response against Methylated Heparin-Binding Hemagglutinin. CVI 12: 1135-1138 [Abstract] [Full Text]  
• Singh, K. K., Dong, Y., Patibandla, S. A., McMurray, D. N., Arora, V. K., Laal, S. (2005). Immunogenicity of the Mycobacterium tuberculosis PPE55 (Rv3347c) Protein during Incipient and Clinical Tuberculosis. Infect. Immun. 73: 5004-5014 [Abstract] [Full Text]  
• Kang, Y. A., Lee, H. W., Yoon, H. I., Cho, B., Han, S. K., Shim, Y.-S., Yim, J.-J. (2005). Discrepancy Between the Tuberculin Skin Test and the Whole-Blood Interferon {gamma} Assay for the Diagnosis of Latent Tuberculosis Infection in an Intermediate Tuberculosis-Burden Country. JAMA 293: 2756-2761 [Abstract] [Full Text]  
• Bonanni, D., Rindi, L., Lari, N., Garzelli, C. (2005). Immunogenicity of mycobacterial PPE44 (Rv2770c) in Mycobacterium bovis BCG-infected mice. J Med Microbiol 54: 443-448 [Abstract] [Full Text]  
• Demangel, C., Garnier, T., Rosenkrands, I., Cole, S. T. (2005). Differential Effects of Prior Exposure to Environmental Mycobacteria on Vaccination with Mycobacterium bovis BCG or a Recombinant BCG Strain Expressing RD1 Antigens. Infect. Immun. 73: 2190-2196 [Abstract] [Full Text]  
• Collins, D. M., Skou, B., White, S., Bassett, S., Collins, L., For, R., Hurr, K., Hotter, G., de Lisle, G. W. (2005). Generation of Attenuated Mycobacterium bovis Strains by Signature-Tagged Mutagenesis for Discovery of Novel Vaccine Candidates. Infect. Immun. 73: 2379-2386 [Abstract] [Full Text]